MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B-Cell Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)-Reference-Cited by-同舟云学术

MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B-Cell Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Published:2002-06 Issue:6 Volume:93 Page:685-694
ISSN:0910-5050
Container-title:Japanese Journal of Cancer Research
language:en
Short-container-title:

Author:

Ito Masato,Iida Shinsuke,Inagaki Hiroshi,Tsuboi Kazuya,Komatsu Hirokazu,Yamaguchi Motoko,Nakamura Naoya,Suzuki Ritsuro,Seto Masao,Nakamura Shigeo,Morishima Yasuo,Ueda Ryuzo

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2002.tb01307.x/fullpdf

Reference51 articles.

1. Chronic Lymphoid Leukemias

2. Immunologic studies of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in Nagasaki district;Kamihira;Jpn. J. Clin. Oncol.,1979

3. Morphological and immunophenotypical characterization of Japanese B-cell lymphocytic leukemia;Kamihira;Leuk. Lymphoma,1994

4. Advances in the biology and treatment of B-cell chronic lymphocytic leukemia;O'Brien;Blood,1995

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment for acceleration and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma using histologic and immunohistochemical features: a case series;Journal of Hematopathology;2024-07-23

2. Immunophenotyping in the Diagnosis and Monitoring of Haematological Neoplasms and Related Conditions with Tables and Figures for Quick Reference;Immunophenotyping for Haematologists;2020-10-13

3. Bone marrow IRF4 level in multiple myeloma: an indicator of peripheral blood Th17 and disease;Oncotarget;2017-08-03

4. Prognostic Impact of MUM1/IRF4 Expression in Burkitt Lymphoma (BL);American Journal of Surgical Pathology;2017-03

5. Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6–deficient process;JCI Insight;2016-04-07